CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in VTRS — Viatris Inc

CIK 884546 SAN FRANCISCO, CA

Back to VTRS Full portfolio

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$184,739,874

+$16,711,039 QoQ

Shares Held

13,674,306

+1.3% QoQ

Ownership

1.17%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

22 quarters on record

Voting authority Sole 99.99610949177237.ToString("F0")% Shared 0.ToString("F0")% None 0.0038905082276204732.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (11.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,717,247	$439,415,767
2	VTRS	Viatris Inc This page	13,674,306	$184,739,874
3	UTHR	UNITED THERAPEUTICS Corp	300,481	$178,179,223
4	NBIX	Neurocrine Biosciences Inc	902,788	$118,933,291
5	ELAN	Elanco Animal Health Inc	3,577,850	$85,617,950
6	ALKS	Alkermes plc.	2,236,756	$79,091,692
7	TEVA	Teva Pharmaceutical Industries Ltd	2,087,679	$62,880,891
8	LNTH	Lantheus Holdings, Inc.	657,413	$49,864,776

All Filings in VTRS

Export CSV

22 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$184,739,874	13,674,306	+1.3%	Shares	Sole	2026-05-15
2025-12-31	$168,028,835	13,496,292	+2.6%	Shares	Sole	2026-02-13
2025-09-30	$130,218,363	13,153,370	+3.4%	Shares	Sole	2025-11-10
2025-06-30	$113,650,413	12,726,810	+4.8%	Shares	Sole	2025-08-12
2025-03-31	$105,817,589	12,148,977	+2.2%	Shares	Sole	2025-09-15
2024-12-31	$148,035,467	11,890,399	+2.3%	Shares	Sole	2025-02-06
2024-09-30	$134,972,310	11,625,522	+1.1%	Shares	Sole	2024-11-12
2024-06-30	$122,213,131	11,497,002	+1.0%	Shares	Sole	2024-08-12
2024-03-31	$135,896,220	11,381,593	+1.9%	Shares	Sole	2024-05-09
2023-12-31	$120,924,379	11,165,686	+3.7%	Shares	Sole	2024-02-06
2023-09-30	$106,187,092	10,769,482	+1.8%	Shares	Sole	2023-11-08
2023-06-30	$105,606,124	10,581,776	+0.3%	Shares	Sole	2023-08-10
2023-03-31	$101,516,656	10,552,667	+1.8%	Shares	Sole	2023-05-12
2022-12-31	$115,377,887	10,366,387	+3.8%	Shares	Sole	2023-02-13
2022-09-30	$85,112,090	9,989,682	+3.4%	Shares	Sole	2022-11-14
2022-06-30	$101,151,591	9,661,088	+2.4%	Shares	Sole	2022-08-15
2022-03-31	$102,667,183	9,436,322	+4.1%	Shares	Sole	2022-05-13
2021-12-31	$122,587,807	9,060,444	+3.9%	Shares	Sole	2022-02-11
2021-09-30	$118,135,268	8,718,470	+2.4%	Shares	Sole	2021-11-16
2021-06-30	$121,636,079	8,511,972	+2.5%	Shares	Sole	2021-08-16
2021-03-31	$116,025,278	8,305,317	+0.2%	Shares	Sole	2021-05-17
2020-12-31	$155,290,827	8,286,597	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.